Search

everythinglearnresearchcommunity

for

Search:↓

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

PRP therapy improves hair growth safely in androgenetic alopecia but needs standardized methods.

Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Human hair contains many different molecules that change along its length, influenced by personal care products.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

Low-level laser therapy can improve hair density in people with androgenic alopecia, but more research is needed to find out who it works best for.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

PRP shows promise for hair restoration with mild side effects, but more research is needed for clear guidelines.

Exosome therapy shows promise for hair growth with minimal side effects, but more research is needed.

People with alopecia areata have a higher risk of heart disease.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.